GlassScriptPhysician profile
Michael J Busuito
NPI 1427080407
$5,652.23
in general payments reported to CMS, 2019-2025
31 companies · $1,883 in 2025
The $1,883 reported for 2025 was more than what 83% of Plastic Surgery providers received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $555 · 2020: $65.29 · 2021: $143 · 2022: $893 · 2023: $493 · 2024: $1,620 · 2025: $1,883.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,580 · Travel and Lodging: $416.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,579.90 |
| Travel and Lodging | $416.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $1,008.37 | 2020-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Abbvie INC. | $760.48 | 2022-2025 | Botox |
| Mentor Worldwide LLC | $515.63 | 2019-2025 | Mentor Memorygel Resterilizable Gel Sizer |
| Kerecis Limited | $386.35 | 2023-2025 | Kerecis Surgiclose, Kerecis Graftguide, Kerecis Omega3 Marigen |
| Sientra, INC. | $338.01 | 2021-2022 | |
| Davol INC. | $315.80 | 2019-2023 | Phasix Mesh |
| Avita Medical Americas, LLC | $280.49 | 2024-2025 | Recell, Permeaderm, Cohealyx |
| Smith+Nephew, INC. | $205.89 | 2019-2025 | Renasys Touch, Renasys Go V2 Home, Pico 7 |
| Solventum Corporation | $194.45 | 2025 | Prevena, Activ.A.C. |
| Revance Therapeutics, INC. | $182.57 | 2024 | Daxxify |
| Organogenesis INC. | $142.86 | 2024 | Puraply Franchise |
| Polynovo North America LLC | $141.17 | 2024 | Novosorb Btm |
| Acell, INC. | $133.96 | 2019 | |
| Heron Therapeutics, INC. | $122.93 | 2025 | Zynrelef |
| Medtronic, INC. | $113.45 | 2022-2025 | V-Loc 180 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tela Bio, INC. | $98.32 | 2022-2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Depuy Synthes Sales INC. | $94.94 | 2024-2025 | Trumatch |
| Mimedx Group, INC. | $84.20 | 2025 | |
| Allergan, INC. | $80.68 | 2019-2022 | |
| Acera Surgical, INC. | $73.12 | 2025 | Restrata Wound Matrix |
| Tepha INC | $68.23 | 2019 | |
| Access Pro Medical, LLC | $56.61 | 2023-2025 | Matriderm, Matriderm |
| Misonix INC | $49.93 | 2020-2021 | |
| Baxter Healthcare | $44.76 | 2025 | Artiss |
| Aroa Biosurgery Incorporated | $35.07 | 2024 | |
| Bioventus LLC | $32.34 | 2022 | |
| Kls-Martin L.P. | $26.35 | 2025 | |
| Motiva USA, LLC | $21.22 | 2025 | |
| Sanara Medtech INC. | $17.44 | 2023 | Celleraterx |
| Apyx Medical Corporation | $15.04 | 2019 | |
| Lifenet Health | $11.57 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Busuito listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.